Grant: Project Grant
McMaster University
$1,193,400.00
The role of the small intestinal microbiota in the development of Irritable Bowel Syndrome.
EF 2023-24
Résumé
The irritable bowel syndrome is a the most common intestinal disorder that imposes a huge socio-economic burden on Canadians. It's cause is unknown but current investigation proposes that it arises from alterations in the trillions of bacteria that reside in our intestines. Studies have been limited to bacteria in the large bowel. However, since this condition is largely influenced by our diet, we propose that bacteria relevant to this condition actually live in the upper part of the intestines where they interact with our diet to produce changes in how the bowel works and hence the symptoms of this common condition. Our study challenges current thinking by focusing on the bacterial composition in the small intestine of patients with irritable bowel syndrome and determines whether these bacteria, rather than those found in the lower bowel, produce alterations in gut function. If correct, our findings would focus on therapies, including dietary change, that would influence bacteria in the upper intestine. Current therapies directed at bacteria in the lower intestines have not been effective.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
501826
Name
Bercik Premysl
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Hematology, Digestive Disease & Kidney
Projecttitle
The role of the small intestinal microbiota in the development of Irritable Bowel Syndrome.
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$1,193,400
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Abdominal Pain; Animal Model; Constipation; Diarrhea; Diet; Gastrointestinal; Irritable Bowel Syndrome; Microbiome; Neuroimmune System; Observational Study
Abstract
The irritable bowel syndrome is a the most common intestinal disorder that imposes a huge socio-economic burden on Canadians. It's cause is unknown but current investigation proposes that it arises from alterations in the trillions of bacteria that reside in our intestines. Studies have been limited to bacteria in the large bowel. However, since this condition is largely influenced by our diet, we propose that bacteria relevant to this condition actually live in the upper part of the intestines where they interact with our diet to produce changes in how the bowel works and hence the symptoms of this common condition. Our study challenges current thinking by focusing on the bacterial composition in the small intestine of patients with irritable bowel syndrome and determines whether these bacteria, rather than those found in the lower bowel, produce alterations in gut function. If correct, our findings would focus on therapies, including dietary change, that would influence bacteria in the upper intestine. Current therapies directed at bacteria in the lower intestines have not been effective.
Competitiondate
202403
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Bercik, Premysl
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $1,193,400~ $0~